Literature DB >> 26277545

Pyruvate kinase: Function, regulation and role in cancer.

William J Israelsen1, Matthew G Vander Heiden2.   

Abstract

Pyruvate kinase is an enzyme that catalyzes the conversion of phosphoenolpyruvate and ADP to pyruvate and ATP in glycolysis and plays a role in regulating cell metabolism. There are four mammalian pyruvate kinase isoforms with unique tissue expression patterns and regulatory properties. The M2 isoform of pyruvate kinase (PKM2) supports anabolic metabolism and is expressed both in cancer and normal tissue. The enzymatic activity of PKM2 is allosterically regulated by both intracellular signaling pathways and metabolites; PKM2 thus integrates signaling and metabolic inputs to modulate glucose metabolism according to the needs of the cell. Recent advances have increased our understanding of metabolic regulation by pyruvate kinase, raised new questions, and suggested the possibility of non-canonical PKM2 functions to regulate gene expression and cell cycle progression via protein-protein interactions and protein kinase activity. Here we review the structure, function, and regulation of pyruvate kinase and discuss how these properties enable regulation of PKM2 for cell proliferation and tumor growth.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer metabolism; PKM2; Pyruvate kinase

Mesh:

Substances:

Year:  2015        PMID: 26277545      PMCID: PMC4662905          DOI: 10.1016/j.semcdb.2015.08.004

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  114 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Small molecule activation of PKM2 in cancer cells induces serine auxotrophy.

Authors:  Charles Kung; Jeff Hixon; Sung Choe; Kevin Marks; Stefan Gross; Erin Murphy; Byron DeLaBarre; Giovanni Cianchetta; Shalini Sethumadhavan; Xiling Wang; Shunqi Yan; Yi Gao; Cheng Fang; Wentao Wei; Fan Jiang; Shaohui Wang; Kevin Qian; Jeff Saunders; Ed Driggers; Hin Koon Woo; Kaiko Kunii; Stuart Murray; Hua Yang; Katharine Yen; Wei Liu; Lewis C Cantley; Matthew G Vander Heiden; Shinsan M Su; Shengfang Jin; Francesco G Salituro; Lenny Dang
Journal:  Chem Biol       Date:  2012-09-21

3.  A linear steady-state treatment of enzymatic chains. General properties, control and effector strength.

Authors:  R Heinrich; T A Rapoport
Journal:  Eur J Biochem       Date:  1974-02-15

4.  A kinetic study of rabbit muscle pyruvate kinase.

Authors:  S Ainsworth; N MacFarlane
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

5.  The mechanism of precursor modulation of human pyruvate kinase I by fructose diphosphate.

Authors:  R D Koler; P Vanbellinghen
Journal:  Adv Enzyme Regul       Date:  1968

6.  Bovine pyruvate kinases. I. Purification and characterization of the skeletal muscle isozyme.

Authors:  J M Cardenas; R D Dyson; J J Strandholm
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

7.  Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Authors:  Matthew G Vander Heiden; Jason W Locasale; Kenneth D Swanson; Hadar Sharfi; Greg J Heffron; Daniel Amador-Noguez; Heather R Christofk; Gerhard Wagner; Joshua D Rabinowitz; John M Asara; Lewis C Cantley
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

8.  Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferation.

Authors:  Bentley Varghese; Gayathri Swaminathan; Alexander Plotnikov; Christos Tzimas; Ning Yang; Hallgeir Rui; Serge Y Fuchs
Journal:  Mol Endocrinol       Date:  2010-10-20

Review 9.  Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.

Authors:  E Eigenbrodt; M Reinacher; U Scheefers-Borchel; H Scheefers; R Friis
Journal:  Crit Rev Oncog       Date:  1992

10.  Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis.

Authors:  Ying-Hua Wang; William J Israelsen; Dongjun Lee; Vionnie W C Yu; Nathaniel T Jeanson; Clary B Clish; Lewis C Cantley; Matthew G Vander Heiden; David T Scadden
Journal:  Cell       Date:  2014-09-11       Impact factor: 41.582

View more
  152 in total

Review 1.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

2.  HIF1 mediates a switch in pyruvate kinase isoforms after myocardial infarction.

Authors:  Allison Lesher Williams; Vedbar Khadka; Mingxin Tang; Abigail Avelar; Kathryn J Schunke; Mark Menor; Ralph V Shohet
Journal:  Physiol Genomics       Date:  2018-04-13       Impact factor: 3.107

Review 3.  Pyruvate kinase M2: A simple molecule with complex functions.

Authors:  Mohammed Alquraishi; Dexter L Puckett; Dina S Alani; Amal S Humidat; Victoria D Frankel; Dallas R Donohoe; Jay Whelan; Ahmed Bettaieb
Journal:  Free Radic Biol Med       Date:  2019-08-08       Impact factor: 7.376

Review 4.  An overview of structure, function, and regulation of pyruvate kinases.

Authors:  Norbert Schormann; Katherine L Hayden; Paul Lee; Surajit Banerjee; Debasish Chattopadhyay
Journal:  Protein Sci       Date:  2019-08-12       Impact factor: 6.725

Review 5.  The Warburg Effect and Mass Spectrometry-based Proteomic Analysis.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

6.  Small molecule cores demonstrate non-competitive inhibition of lactate dehydrogenase.

Authors:  Brooke A Andrews; R Brian Dyer
Journal:  Medchemcomm       Date:  2018-07-13       Impact factor: 3.597

Review 7.  Understanding the Intersections between Metabolism and Cancer Biology.

Authors:  Matthew G Vander Heiden; Ralph J DeBerardinis
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 8.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

9.  Determining protein biomarkers for DLBCL using FFPE tissues from HIV negative and HIV positive patients.

Authors:  Pumza Magangane; Raveendra Sookhayi; Dhirendra Govender; Richard Naidoo
Journal:  J Mol Histol       Date:  2016-10-01       Impact factor: 2.611

Review 10.  Lactate modulation of immune responses in inflammatory versus tumour microenvironments.

Authors:  Michelangelo Certo; Chin-Hsien Tsai; Valentina Pucino; Ping-Chih Ho; Claudio Mauro
Journal:  Nat Rev Immunol       Date:  2020-08-24       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.